Abstract
Procalcitonin serum level has been recommended as a new marker of bacterial infectious diseases. The aim of this prospective, multicenter study was to determine the clinical usefulness of procalcitonin in differentiating patients with sepsis from those with severe sepsis. Eighty-two patients were enrolled: 20 without systemic inflammatory response syndrome (SIRS), 9 with SIRS, 34 with sepsis, and 19 with severe sepsis. The patients with severe sepsis had significantly higher procalcitonin levels (median, 36.1 ng/ml) than those with sepsis (median, 0.6 ng/ml). With a procalcitonin cutoff value of 2.0 ng/ml, sensitivity for the detection of severe sepsis and specificity for the detection of sepsis were 94.7% and 78.1%, respectively. A good correlation was found between the serum procalcitonin level and the Sepsis-Related Organ Failure Assessment (SOFA) score (r = 0.680), although no correlation was found between the C-reactive protein (CRP) level and the SOFA score. In conclusion, the procalcitonin serum level may be useful not only for aiding the diagnosis of sepsis but also for discriminating between sepsis and severe sepsis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Vincent JL, Moreno R, Takala J, Willatts S, Meodonca AD, Bruining H, et al. The SOFA (Sepsis-Related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996;22:707–710.
Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818–829.
ACCP/SCCM Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for use of innovative therapies in sepsis. Crit Care Med 1992;20:864–874.
Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS) — a prospective study. JAMA 1995;273:117–123.
Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515–518.
Gendrel D, Raymond J, Coste J, Moulin F, Lorrot M, Guerin S, et al. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differential of bacterial vs viral infections. Pediatr Infect Dis 1999;18:875–881.
Delevaux I, Andre M, Colombier M, Albuission E, Meylheuc F, Begue RJ, et al. Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis 2003;62:337–340.
Gendrel D, Bohuon C. Procalcitonin in pediatrics for differentiation of bacterial and viral infection. Intensive Care Med 2000;26:178–181.
Ugarte H, Silva E, Mercan D, Mendonca AD, Vincent JL. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999;27:498–504.
Meisner M, Tschaikowsky K, Schmidt J, Schuttler J. Procalcitonin (PCT) — indications for a new diagnostic parameter of severe bacterial infection and sepsis in transplantation, immunosuppression and cardiac assist devices. Cardiovasc Eng 1996;1:67–76.
Nylen ES, Whang KT, Snider RH, Steinward PM, White JC, Becker KL. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med 1998;26:1001–1006.
Aikawa N, Fujishima S, Endo S, Sekine I, Kogawa K, Yamamoto Y, et al. Multicenter prospective study of procalcitonin as an indicator of sepsis. J Infect Chemother 2005;11:52–159.
Reinhart K, Karzai W, Meisner M. Procalcitonin as a marker of the systemic inflammatory response to infection. Intensive Care Med 2000;26:1193–1200.
Kambayashi J, Yokota M, Sakon M, Shiba E, Kawasaki T, Mori T, et al. A novel endotoxin-specific assay by turbidimetry with Limulus amoebocyte lysate containing β-glucan. J Biochem Biophys Methods 1991;22:93–100.
Mori T, Ikemoto H, Matsumura M, Yoshida M, Ikeda K, Endo S, et al. Evaluation of plasma (1–3)-D-glucan measurement by the kinetic turbidimetric Limulus test, for the clinical diagnosis of mycotic infections. Eur J Clin Chem Clin Biochem 1997;35:553–560.
Mori T, Ikemoto H, Matsumura M. Clinical evaluation of diagnostic methods using plasma and/or serum for three mycoses: Aspergillosis, Candidosis, and Pneumocystosis. Jpn J Med Mycol 1999;40:223–230.
Fukae K, Saitoh H. Sequential Organ Failure Assessment score (SOFA score) (in Japanese). Shokaki Geka 2002;5:63–567.
Itoh N, Shinozawa Y. APACHE II/APACHE III (in Japanese). Shokaki Geka 2002;5:45–552.
Brunkhorst FM, Wegscheider K, Forycki ZF, Brunkhorst R. Procalcitonin for early diagnosis and differentiation of SIRS. sepsis, severe sepsis, and septic shock. Intensive Care Med 2000;26:148–152.
Meisner M, Tschaikowsky K, Palmaers T, Schmidt J. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care 1999;3:45–50.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Endo, S., Aikawa, N., Fujishima, S. et al. Usefulness of procalcitonin serum level for the discrimination of severe sepsis from sepsis: a multicenter prospective study. J Infect Chemother 14, 244–249 (2008). https://doi.org/10.1007/s10156-008-0608-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10156-008-0608-1